It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Mechanisms by which G-patch activators tune the processive multi-tasking ATP-dependent RNA helicase Prp43 (DHX15 in humans) to productively remodel diverse RNA:protein complexes remain elusive. Here, a comparative study between a herein and previously characterized activators, Tma23 and Pxr1, respectively, defines segments that organize Prp43 function during ribosome assembly. In addition to the activating G-patch, we discover an inhibitory segment within Tma23 and Pxr1, I-patch, that restrains Prp43 ATPase activity. Cryo-electron microscopy and hydrogen-deuterium exchange mass spectrometry show how I-patch binds to the catalytic RecA-like domains to allosterically inhibit Prp43 ATPase activity. Tma23 and Pxr1 contain dimerization segments that organize Prp43 into higher-order complexes. We posit that Prp43 function at discrete locations on pre-ribosomal RNA is coordinated through toggling interactions with G-patch and I-patch segments. This could guarantee measured and timely Prp43 activation, enabling precise control over multiple RNA remodelling events occurring concurrently during ribosome formation.
Portugal-Calisto et al report the discovery of a 14-residue inhibitory segment, I-patch, present within G-patch activators, Tma23 and Pxr1, that restrains the ATPase activity of the DEAH-RNA helicase Prp43 during ribosome assembly.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Rabl, Julius 2 ; Vadas, Oscar 3
; Oborská-Oplová, Michaela 1
; Mazur, Jarosław 1
; Richina, Federica 4 ; Klingauf-Nerurkar, Purnima 5 ; Michel, Erich 6
; Leitner, Alexander 7
; Boehringer, Daniel 2
; Panse, Vikram Govind 8
1 University of Zurich, Institute of Medical Microbiology, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650)
2 ETH Zurich, Cryo-EM Knowledge Hub, Zurich, Switzerland (GRID:grid.5801.c) (ISNI:0000 0001 2156 2780)
3 University of Geneva, Faculty of Medicine, Geneva, Switzerland (GRID:grid.8591.5) (ISNI:0000 0001 2175 2154)
4 ETH Zurich, Institute of Biochemistry, Zurich, Switzerland (GRID:grid.5801.c) (ISNI:0000 0001 2156 2780)
5 University of Zurich, Institute of Medical Microbiology, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650); ETH Zurich, Institute of Biochemistry, Zurich, Switzerland (GRID:grid.5801.c) (ISNI:0000 0001 2156 2780)
6 University of Zurich, Department of Biochemistry, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650)
7 ETH Zurich, Institute of Molecular Systems Biology, Zurich, Switzerland (GRID:grid.5801.c) (ISNI:0000 0001 2156 2780)
8 University of Zurich, Institute of Medical Microbiology, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650); University of Zurich, Faculty of Science, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650)




